# Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

> **NCT04854005** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 78 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Breast surgery

## Key facts

- **NCT ID:** NCT04854005
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-20
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854005, "Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04854005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*